Correlation Between Taro Pharmaceutical and Eagle Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Taro Pharmaceutical and Eagle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taro Pharmaceutical and Eagle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taro Pharmaceutical Industries and Eagle Pharmaceuticals, you can compare the effects of market volatilities on Taro Pharmaceutical and Eagle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taro Pharmaceutical with a short position of Eagle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taro Pharmaceutical and Eagle Pharmaceuticals.

Diversification Opportunities for Taro Pharmaceutical and Eagle Pharmaceuticals

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Taro and Eagle is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Taro Pharmaceutical Industries and Eagle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eagle Pharmaceuticals and Taro Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taro Pharmaceutical Industries are associated (or correlated) with Eagle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eagle Pharmaceuticals has no effect on the direction of Taro Pharmaceutical i.e., Taro Pharmaceutical and Eagle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Taro Pharmaceutical and Eagle Pharmaceuticals

Given the investment horizon of 90 days Taro Pharmaceutical Industries is expected to generate 0.43 times more return on investment than Eagle Pharmaceuticals. However, Taro Pharmaceutical Industries is 2.34 times less risky than Eagle Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Eagle Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest  2,915  in Taro Pharmaceutical Industries on August 28, 2024 and sell it today you would earn a total of  1,382  from holding Taro Pharmaceutical Industries or generate 47.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy83.6%
ValuesDaily Returns

Taro Pharmaceutical Industries  vs.  Eagle Pharmaceuticals

 Performance 
       Timeline  
Taro Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taro Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taro Pharmaceutical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Eagle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eagle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Taro Pharmaceutical and Eagle Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Taro Pharmaceutical and Eagle Pharmaceuticals

The main advantage of trading using opposite Taro Pharmaceutical and Eagle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taro Pharmaceutical position performs unexpectedly, Eagle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eagle Pharmaceuticals will offset losses from the drop in Eagle Pharmaceuticals' long position.
The idea behind Taro Pharmaceutical Industries and Eagle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments